MaxCyte, Inc.
MXCT
$2.04
-$0.02-0.97%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -41.79M | -41.06M | -35.74M | -35.43M | -36.57M |
| Total Depreciation and Amortization | 4.96M | 4.91M | 4.87M | 4.89M | 4.83M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10.38M | 9.29M | 8.32M | 7.63M | 7.36M |
| Change in Net Operating Assets | -5.01M | -751.00K | 3.74M | 259.00K | -3.55M |
| Cash from Operations | -31.46M | -27.61M | -18.81M | -22.66M | -27.93M |
| Capital Expenditure | -1.50M | -1.65M | -2.42M | -2.73M | -2.95M |
| Sale of Property, Plant, and Equipment | -- | -- | 0.00 | 0.00 | 0.00 |
| Cash Acquisitions | -1.77M | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 34.13M | 8.58M | 6.88M | 6.40M | 13.90M |
| Cash from Investing | 30.86M | 6.93M | 4.46M | 3.66M | 10.95M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.74M | 2.06M | 2.14M | 1.95M | 1.39M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.74M | 2.06M | 2.14M | 1.95M | 1.39M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.14M | -18.62M | -12.21M | -17.05M | -15.59M |